These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23728610)

  • 21. D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia.
    Stam RW; den Boer ML; Schneider P; Meier M; Beverloo HB; Pieters R
    Haematologica; 2007 Nov; 92(11):1565-8. PubMed ID: 18024407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rearrangements of the mixed lineage leukemia gene in acute myeloid leukemia].
    Zhang LJ; Lu XL; He J; Li Y
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2256-60. PubMed ID: 17064570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PAFc, a key player in MLL-rearranged leukemogenesis.
    Tan J; Muntean AG; Hess JL
    Oncotarget; 2010 Oct; 1(6):461-5. PubMed ID: 21037944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent inhibition of DOT1L as treatment of MLL-fusion leukemia.
    Daigle SR; Olhava EJ; Therkelsen CA; Basavapathruni A; Jin L; Boriack-Sjodin PA; Allain CJ; Klaus CR; Raimondi A; Scott MP; Waters NJ; Chesworth R; Moyer MP; Copeland RA; Richon VM; Pollock RM
    Blood; 2013 Aug; 122(6):1017-25. PubMed ID: 23801631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The molecular basis of leukemogenesis caused by MLL gene rearrangements].
    Yokoyama A
    Rinsho Ketsueki; 2015 Oct; 56(10):1942-9. PubMed ID: 26458432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration of microRNA function impairs MYC-dependent maintenance of MLL leukemia.
    Zhu S; Cheng X; Wang R; Tan Y; Ge M; Li D; Xu Q; Sun Y; Zhao C; Chen S; Liu H
    Leukemia; 2020 Sep; 34(9):2484-2488. PubMed ID: 32094460
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9.
    Secker KA; Keppeler H; Duerr-Stoerzer S; Schmid H; Schneidawind D; Hentrich T; Schulze-Hentrich JM; Mankel B; Fend F; Schneidawind C
    Oncogene; 2019 Nov; 38(46):7181-7195. PubMed ID: 31417187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia.
    Mi S; Li Z; Chen P; He C; Cao D; Elkahloun A; Lu J; Pelloso LA; Wunderlich M; Huang H; Luo RT; Sun M; He M; Neilly MB; Zeleznik-Le NJ; Thirman MJ; Mulloy JC; Liu PP; Rowley JD; Chen J
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3710-5. PubMed ID: 20133587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia.
    Sharma A; Jyotsana N; Gabdoulline R; Heckl D; Kuchenbauer F; Slany RK; Ganser A; Heuser M
    Haematologica; 2020 May; 105(5):1294-1305. PubMed ID: 31413090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia.
    Guenther MG; Lawton LN; Rozovskaia T; Frampton GM; Levine SS; Volkert TL; Croce CM; Nakamura T; Canaani E; Young RA
    Genes Dev; 2008 Dec; 22(24):3403-8. PubMed ID: 19141473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-181a enhances drug sensitivity of mixed lineage leukemia-rearranged acute myeloid leukemia by increasing poly(ADP-ribose) polymerase1 acetylation.
    Zhou D; Xu P; Zhou X; Diao Z; Ouyang J; Yan G; Chen B
    Leuk Lymphoma; 2021 Jan; 62(1):136-146. PubMed ID: 32996365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interaction between mixed-lineage leukemia and Menin proteins].
    Liu L; Li BS; Ye QD; He YY; Tang JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1130-4. PubMed ID: 19840436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic DNA of leukemic patients: target for clinical diagnosis of MLL rearrangements.
    Meyer C; Kowarz E; Schneider B; Oehm C; Klingebiel T; Dingermann T; Marschalek R
    Biotechnol J; 2006 Jun; 1(6):656-63. PubMed ID: 16892314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paradoxical Effects of MLL Paralogs in MLL-Rearranged Leukemia.
    Thirman MJ
    Cancer Cell; 2017 Jun; 31(6):729-731. PubMed ID: 28609652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-150:targeting MLL leukemia.
    Jiang X; Chen J
    Oncotarget; 2012 Nov; 3(11):1268-9. PubMed ID: 23175472
    [No Abstract]   [Full Text] [Related]  

  • 36. MLL-AF4+ infant leukemia: a microRNA affair.
    Schwaller J
    Blood; 2021 Nov; 138(21):2014-2015. PubMed ID: 34821939
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of MLL methyltransferase gene expression in larynx carcinoma.
    Figueiredo DL; do Amaral Rabello D; Zanette DL; Saggioro FP; Mamede RC; Zago MA; da Silva WA; Saldanha-Araújo F; Pittella Silva F
    Oncol Rep; 2015 Apr; 33(4):2017-22. PubMed ID: 25633166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rewiring the Epigenetic Networks in
    Chan AKN; Chen CW
    Front Cell Dev Biol; 2019; 7():81. PubMed ID: 31157223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition.
    Kühn MW; Hadler MJ; Daigle SR; Koche RP; Krivtsov AV; Olhava EJ; Caligiuri MA; Huang G; Bradner JE; Pollock RM; Armstrong SA
    Haematologica; 2015 May; 100(5):e190-3. PubMed ID: 25596271
    [No Abstract]   [Full Text] [Related]  

  • 40. The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia.
    Wu W; Jiang Y; Xing D; Zhai Y; Sun H; He X; Luo K; Xu P; Pan F; Dong G; Ren G; Zhao Z
    Cell Death Discov; 2024 May; 10(1):206. PubMed ID: 38693103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.